MACIE CABLE: Open Payments
NPI 1427785328 · CHATSWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 37 payments from 14 companies in 2025. Trend: 2023 $15 · 2024 $932 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $136 |
| ABBVIE INC. | 5 | $119 |
| PFIZER INC. | 5 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Lilly USA, LLC | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Medtronic, Inc. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: VRAYLAR, Wegovy, ELIQUIS, XIFAXAN, CAPLYTA, PREVNAR 20, Auvelity, Ozempic.
Industry payments across GA — which companies pay providers there.
